Ardelyx (ARDX) Inventory (2022 - 2026)
Ardelyx's (ARDX) quarterly Inventory came in at $22.7 million in Q1 2026, down 4.34% YoY from $23.8 million in Q1 2025, and up 28.25% on a QoQ basis from $17.7 million in Q4 2025.
Ardelyx (ARDX) Inventory (2022 - 2026) Analysis & Trends
Ardelyx (ARDX) has 5 years of Inventory data on file, last reported at $22.7 million in Q1 2026.
- Quarterly Inventory fell 4.34% year-over-year to $22.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.7 million (down 4.34% YoY) and the FY2025 annual result came in at $17.7 million, down 16.24% from the prior year.
- Inventory climbed to $22.7 million in Q1 2026, from $17.7 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $25.2 million in Q3 2025 to a low of $1.2 million in Q3 2022.
- A 5-year average of $12.6 million and a median of $11.4 million in 2024 frame the typical range for Inventory.
- Annual changes were most pronounced in 2023 — Inventory surged 581.92% — and 2025, when it slipped 16.24%.
- Tracing ARDX's Inventory over 5 years: stood at $3.3 million in 2022, then jumped by 279.28% to $12.4 million in 2023, then surged by 70.09% to $21.2 million in 2024, then fell by 16.24% to $17.7 million in 2025, then advanced by 28.25% to $22.7 million in 2026.
- The last three Inventory figures came in at $22.7 million (Q1 2026), $17.7 million (Q4 2025), and $25.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn | 25.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.86 Mn |
| Mar 31, 2026 | 22.75 Mn |
| Dec 31, 2025 | 17.74 Mn |
| Sep 30, 2025 | 25.17 Mn |
| Jun 30, 2025 | 22.28 Mn |
| Mar 31, 2025 | 23.78 Mn |
| Dec 31, 2024 | 21.17 Mn |
| Sep 30, 2024 | 11.38 Mn |
| Jun 30, 2024 | 13.76 Mn |
| Mar 31, 2024 | 9.81 Mn |
| Dec 31, 2023 | 12.45 Mn |
| Sep 30, 2023 | 8.52 Mn |
| Jun 30, 2023 | 7.62 Mn |
| Mar 31, 2023 | 4.82 Mn |
| Dec 31, 2022 | 3.28 Mn |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 4.53 Mn |
| Mar 31, 2022 | 3.49 Mn |